Integration of virtual platforms for enhanced conference experience: Data-based evidence from the Society of Interdisciplinary Placebo Studies 2021 conference.
SIPS
addiction
alcohol
expectations
pain
placebo
virtual conference
Journal
Frontiers in communication
ISSN: 2297-900X
Titre abrégé: Front Commun (Lausanne)
Pays: Switzerland
ID NLM: 101714787
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
9
9
2022
pubmed:
10
9
2022
medline:
10
9
2022
Statut:
ppublish
Résumé
The Society of Interdisciplinary Placebo Studies (SIPS) was one of many organizations that hosted a virtual scientific conference in response to the COVID-19 pandemic restrictions. Retaining essential benefits of an in-person conference experience was a primary objective for the SIPS conference planning committee and guided the selection of a virtual platform on which to host the 2021 meeting. This article reports on the methods used to design and analyze an engaging, virtual scientific conference, along with the findings and implications for future meetings. Participant use of and interaction with different features of the conference platform were recorded and exported for analysis. Additionally, all SIPS conference attendees were invited to complete a brief, online post-conference survey that inquired about their perceptions of the SIPS conference specifically as well as their opinions of virtual and hybrid conferences in general. Using these data, we assessed (1) attendance patterns, (2) level of engagement, and (3) attendee satisfaction. The platform recorded 438 unique, active conference attendees who used either a mobile app, web browser, or both to participate during the 3-day program. Seventy-four percent ( Results of data analyses suggest the virtual platform allowed for those who were unable to attend to join virtually, produced moderate engagement throughout the conference, and that the majority of attendees were satisfied with the quality of the fully-virtual conference. Therefore, incorporating virtual aspects in future in-person conferences could enhance conference experience and participation.
Sections du résumé
Background
UNASSIGNED
The Society of Interdisciplinary Placebo Studies (SIPS) was one of many organizations that hosted a virtual scientific conference in response to the COVID-19 pandemic restrictions. Retaining essential benefits of an in-person conference experience was a primary objective for the SIPS conference planning committee and guided the selection of a virtual platform on which to host the 2021 meeting. This article reports on the methods used to design and analyze an engaging, virtual scientific conference, along with the findings and implications for future meetings.
Methods
UNASSIGNED
Participant use of and interaction with different features of the conference platform were recorded and exported for analysis. Additionally, all SIPS conference attendees were invited to complete a brief, online post-conference survey that inquired about their perceptions of the SIPS conference specifically as well as their opinions of virtual and hybrid conferences in general. Using these data, we assessed (1) attendance patterns, (2) level of engagement, and (3) attendee satisfaction.
Results
UNASSIGNED
The platform recorded 438 unique, active conference attendees who used either a mobile app, web browser, or both to participate during the 3-day program. Seventy-four percent (
Conclusion
UNASSIGNED
Results of data analyses suggest the virtual platform allowed for those who were unable to attend to join virtually, produced moderate engagement throughout the conference, and that the majority of attendees were satisfied with the quality of the fully-virtual conference. Therefore, incorporating virtual aspects in future in-person conferences could enhance conference experience and participation.
Identifiants
pubmed: 36081878
doi: 10.3389/fcomm.2022.857661
pmc: PMC9451137
mid: NIHMS1834211
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIAAA NIH HHS
ID : R13 AA028424
Pays : United States
Déclaration de conflit d'intérêts
Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Pathol Inform. 2021 Mar 15;12:11
pubmed: 34012715
Proc Biol Sci. 2021 Oct 27;288(1961):20211769
pubmed: 34666518
EMBO Rep. 2020 Jul 3;21(7):e50883
pubmed: 32510697
Br J Anaesth. 2021 Mar;126(3):e116-e118
pubmed: 33358043
Trends Microbiol. 2020 Dec;28(12):949-952
pubmed: 32978058
Clin Dermatol. 2021 May-Jun;39(3):461-466
pubmed: 34518005
Dermatol Online J. 2020 Jul 15;26(7):
pubmed: 32898410
AEM Educ Train. 2020 Jun 13;4(3):270-274
pubmed: 32704598
J Am Soc Mass Spectrom. 2022 Feb 2;33(2):238-241
pubmed: 35005981
Gigascience. 2021 Aug 20;10(8):
pubmed: 34414422
CJEM. 2021 Sep;23(5):696-699
pubmed: 34264507
Am J Health Syst Pharm. 2020 Oct 30;77(22):1826-1827
pubmed: 32780787
OTA Int. 2021 Feb 23;4(1):e117
pubmed: 33937721
Biol Open. 2020 Oct 23;9(10):
pubmed: 33175696
Can Med Educ J. 2021 Sep 14;12(4):65-69
pubmed: 34567306
Cell Transplant. 2021 Jan-Dec;30:9636897211053872
pubmed: 34669545
BJPsych Bull. 2022 Jun;46(3):181-187
pubmed: 33949303
J Med Toxicol. 2020 Oct;16(4):353-355
pubmed: 32839942
Ann Clin Transl Neurol. 2021 Feb;8(2):525-528
pubmed: 33352002
Front Res Metr Anal. 2021 Jul 23;6:699782
pubmed: 34368615
Nat Rev Mater. 2022;7(3):153-154
pubmed: 35035997
Wellcome Open Res. 2021 Jun 16;6:156
pubmed: 34405119
J Med Internet Res. 2021 Apr 21;23(4):e24369
pubmed: 33844635
Innov Surg Sci. 2021 Nov 09;6(3):115-123
pubmed: 35224179
Neurosurg Focus. 2020 Dec;49(6):E17
pubmed: 33260121
ATS Sch. 2020 Jul 30;1(3):307-315
pubmed: 33870297
BMC Med Educ. 2022 Jan 3;22(1):10
pubmed: 34980077
JMIR Med Educ. 2021 Nov 12;7(4):e33861
pubmed: 34766916
J Educ Perioper Med. 2021 Jul 1;23(3):E667
pubmed: 34631965
Outlook Agric. 2020 Dec;49(4):321-329
pubmed: 33281231
Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):315-321
pubmed: 33373657
World Neurosurg. 2021 Apr;148:e415-e424
pubmed: 33453425
Eur J Neurol. 2021 Aug;28(8):2523-2532
pubmed: 33369806
Nature. 2021 Mar;591(7849):185-186
pubmed: 33654258
Disaster Med Public Health Prep. 2020 Oct 26;:1-6
pubmed: 33100253
J Med Imaging Radiat Oncol. 2020 Jun;64(3):414-421
pubmed: 32304265
BJU Int. 2021 Feb;127(2):263-265
pubmed: 33547719